Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

NCT01458600 is registered in ClinicalTrials.gov with Mikael Lantz as lead sponsor.

NCT NCT01458600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01458600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
Lead sponsor
Mikael Lantz
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
February 29, 2016
Enrollment
65 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

graves´ disease